West Chester, PA, United States of America

Robert J Chorvat

USPTO Granted Patents = 48 

 

 

Average Co-Inventor Count = 2.5

ph-index = 14

Forward Citations = 647(Granted Patents)


Location History:

  • West Chester, PA (US) (2000 - 2014)
  • Chadds Ford, PA (US) (2014 - 2023)

Company Filing History:


Years Active: 2000-2023

Loading Chart...
Loading Chart...
Loading Chart...
48 patents (USPTO):Explore Patents

Title: Robert J. Chorvat: Innovator in Anti-Arrhythmic Agents

Introduction

Robert J. Chorvat is a prominent inventor based in West Chester, PA, with a remarkable portfolio of 48 patents to his name. His work primarily focuses on the development of novel pharmaceutical agents targeting cardiac arrhythmias, showcasing his commitment to advancing medical treatment options.

Latest Patents

Chorvat's latest innovations include significant advancements in ultra-short acting anti-arrhythmic agents. One of these patents presents novel dofetilide derivatives and pharmaceutical compositions that serve as effective treatments for supraventricular and ventricular arrhythmias. Another of his recent inventions involves novel sotalol derivatives, which similarly aim to address various types of arrhythmias, enhancing the therapeutic landscape for patients suffering from these conditions.

Career Highlights

Throughout his career, Robert J. Chorvat has collaborated with notable companies such as Jenrin Discovery, Inc. and Dupont Pharmaceuticals Company. His contributions within these organizations have been pivotal in shaping the development of innovative solutions in the field of cardiovascular medicine.

Collaborations

Chorvat's work has often been in tandem with distinguished colleagues such as John Francis McElroy and Paul Joseph Gilligan. These collaborations have enriched his projects and broadened the horizons of research in pharmaceutical compositions, leading to new pathways in medical treatment.

Conclusion

Robert J. Chorvat’s extensive portfolio and collaborative endeavors make him a significant figure in pharmaceutical innovation. His commitment to developing cutting-edge treatments for cardiac arrhythmias not only underscores his expertise but also reflects the transformative potential of his inventions in improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…